SONENDO INC

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch SONENDO INC and buy or sell other stocks, ETFs, and their options commission-free!

About SONX

Sonendo, Inc. is a medical technology company, which developed and manufactures the GentleWave System to treat tooth decay. It operates through the Product and Software segments. 

CEO
Bjarne Bergheim
CEOBjarne Bergheim
Employees
216
Employees216
Headquarters
Laguna Hills, California
HeadquartersLaguna Hills, California
Founded
2006
Founded2006
Employees
216
Employees216

SONX Key Statistics

Market cap
422.22K
Market cap422.22K
Price-Earnings ratio
-0.03
Price-Earnings ratio-0.03
Dividend yield
Dividend yield
Average volume
2.36K
Average volume2.36K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$80.00
52 Week high$80.00
52 Week low
$1.00
52 Week low$1.00

Stock Snapshot

With a market cap of 422.22K, SONENDO INC(SONX) trades at $1.01. The stock has a price-to-earnings ratio of -0.03.

SONENDO INC(SONX) stock opened on 2026-07-25 at —. The price climbed to — and dipped to —.

The SONENDO INC(SONX)'s current trading volume is 0, compared to an average daily volume of 2.36K.

During the past year, SONENDO INC(SONX) stock moved between $1.00 at its lowest and $80.00 at its peak.

During the past year, SONENDO INC(SONX) stock moved between $1.00 at its lowest and $80.00 at its peak.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.